Introduction
This review highlights some of the technical features that currently influence the use of cell transplantation as a therapeutic approach to neuronal disease. We focus on two technical developments that may contribute to the extension of the implantation approach. First, we have developed precise stereotactic methods for use in the newborn rodent brain. Secondly, we have shown that immortalized precursor cells are capable of extensive differentiation when transplanted into the developing brain. The implications of these two developments are discussed with reference to transplant therapies.
Grafting cells into specific sites of the mature and developing brain is in many ways the ultimate assay for the functional capacities of the cells of interest. While neural grafting has become important in many aspects of neurobiology and is showing promise as a therapy in neurodegenerative diseases, surprisingly little attention has been given to details of the grafting technique itself. The delivery method and placement of cells at precise targets in the brain is of crucial importance. Such technical conscientiousness may determine the success or failure of a neural graft -whether it is in a newborn rodent or a patient with Parkinson's disease.
Stereotactic methods for use in the newborn rodent brain
Stereotactic surgical techniques enable researchers to locate and manipulate structures in the adult brain with great accuracy. Such surgical precision in the very young $41 newborn rodent would allow researchers elegantly to investigate neural systems in the developing animal. However, there are many considerations that must be taken into account when devising a neonatal stereotactic technique. Because ossification is incomplete in the newborn, the skull is very thin and elastic; this poses a number of practical difficulties. The greatest problem is in securing the head in a fixed and rigid position which is reproducible, without distorting or shifting the brain in the cranium. Stabilizing the head is difficult in the newborn since the external auditory meati, which accept earbars in the adult, are under-developed. Very young neonates lack front incisors as well, which in adult sterotactic surgery are hooked over a tooth bar. The cartilaginous nature of the skull also becomes troublesome when attempting to penetrate the skull or produce a craniectomy without damaging the underlying tissue. Moreover, skull sutures are not yet fully established and the identification of landmarks such as bregma and lambda can be ambiguous These mechanical issues can be overcome and, with the help of an adaptor for a standard stereotactic rig, cells can be grafted to precise locations in the central nervous system of newborn rodents [7, 8] .
Special consideration must also be given to the method of anesthesia used for newborns. Immature animals have lower levels of serum albumin and body fat which contribute to the diminished efficacy of conventional anesthetics, such as barbiturates used in adults [3] . The method of choice for reliable anaesthesia of neonatal rodents is hypothermia [10] . However after the animal is about seven days of age, this method is no longer safe and practical, and alternative methods must be used.
The potential importance of the newborn developing brain as a model system for the study of brain disorders has, by and large, been slighted in neural transplantation as a therapeutic approach. The majority of studies have been conducted in the adult and for evident reasons. Neurodegenerative disorders occur in the adult, usually the aged, and so it is the mature brain which must be studied and manipulated if disease is to be treated. However transplantation into the newborn brain may provide important insights into the processes of neural differentiation that can be transferred to the adult situation. Embryonic tissue taken from the ventral mesencephalon and grafted into the substantia nigra of the 6-OHDA lesioned newborn survives and reinnervates the striatum (Nikkah G, Bjorklund A, Cunningham M and McKay R in preparation). This demonstration of the re-establishment of the nigro-striatal pathway may contribute to identifying the factors which allow this reconstruction to occur in neonates but not in the adult.
For many years, transplantation scientists have known that grafts of fetal nigral tissue implanted into the dopamine (DA) denervated striatum can restore DA neurotransmission in the grafted area and reverse some of the behavioural deficits induced by a neurotoxic lesion of the nigrostriatal DA pathway [4, 5, 21] . The efficacy of the standard transplantation approach, however, has several clear-cut limitations: first, with current grafting procedures the survival rate of the grafted DA neuroblasts and young postmitotic DA neurons is only in the range of 5-10%. Secondly, although graft-derived DA release (as measured by microdialysis) can be close to normal in the area surrounding the grafts [15, 20] the striatal tissue DA levels are restored, on average, only to about 10-20% of normal [9, 17, 19] . Finally, the behavioral recovery seen in the grafted animals is incomplete; while certain aspects of the lesion-induced deficits (such as drug-induced motor asymmetry and simple sensorimotor orienting responses) show complete or almost complete recovery, the deficits in more complex tasks (such as skilled paw use and so called disengage behavior) remain unaffected [9, 14] . By disseminating multiple microvolume grafts into the lesioned striatum, these limitations are beginning to be addressed. However, complete recovery of the complex behavioral deficits is only being approached, and may necessitate a more comprehensive reconstruction of the mesostriatal system.
Cultured neuronal cells for implantation therapy
Although these results show promise, transplantation of fetal tissue is faced with inherent ethical and technological pitfalls. The use of human tissues, particularly of the unborn, will invariably cause social reacton, even violent reaction. A further complication is the impending need for more tissue. As reviewed by Bjorklund [6] , approximately 10-15 fetuses may be necessary to achieve a significant level of recovery in a single patient. It also must be considered that many aborted fetuses cannot be used due to defacement and/or contamination during extraction or because of maternal disease.
Culturing tissues, and perhaps expanding the cells of interest, is becoming a more realistic alternative. Immortalized cell lines have been derived from the developing brain by a variety of methods [2, 11, 13, 18] . Some of these cell lines express the neural epithelial stem cell antigen (nestin) for prolonged periods in culture, though nestin expression is transient in vivo [12] . The stable expression of the nestin protein in immortalized cells suggest that they retain some features of primary stem cells, and that they may not easily be able to develop beyond the precursor cell stage. To facilitate the differentiation of nestin-positive immortal stem cells, they have been immortalized using a temperature-conditional oncogene, the tsA58 allele of SV40 large T-antigen (T-antigen). Such immortal cell lines, which grow well at 33°C, have been established from early postnatal cerebellum [16] and optic nerve [1] . Placing the cells at 39°C can result in loss of precursor properties and the acquisition of morphological and biochemical characterstics of differentiated cells.
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However, this transition is difficult to observe in simple in vitro systems. For a full assessment of the developmental capacity of a cell line, it may be critical to place this into an ideal environment. Since the non-permissive temperature of the tsA58 allele of T-antigen is the same as the body temperature of rodents, stem cells immortalized with this gene can theoretically be implanted into the developing brain, where the temperature should inhibit oncogene function, exposing the cells to appropriate extracellular cues. This opportunity served as the incentive for studies involving the in vivo characterization of the immortalized hippocampal cell line, HiB5.
The fate and organization of cells comprising the central nervous system is determined by a complex orchestration of genetic and epigenetic factors. This becomes evident when considering the myriad transplantation observations either promoting the importance of environmental conditions or providing evidence that cell fate is lineage determined. McConnell [15] emphasised that although at early stages a stem cell may be pluripotential, cells become progressively less plastic as brain structure develops. To what extent, though, are stem cells pluripotent? McConnell further stated that "it remains unclear whether individual precursors could be cajoled into altering their fates if transplanted individually or in small groups". Recent work from our laboratory addresses this issue and suggests that primary cerebellar cells grafted to the developing hippocampus differentiate into neurons appropriate to the implant site (Cunningham M, Vicario C, McKay R in preparation). Nestin-positive cells derived from the embryonic hippocampus proliferate for at least 30 days and in vitro partially differentiate to a neuronal fate; in contrast, striking neuronal differentiation occurs when these cells are transplanted to the developing hippocampus. The proliferation of cultured embryonic hippocampal cells slows after two weeks in vitro but nestin-positive cells immmrtalized with SV40 T-antigen grow indefinitely in tissue culture. Following transplantation into the developing hippocampus or cerebellum, these implanted cells differentiate to neurons appropriate to the implant site.
